Related Experiment Videos
Immunospecific NMR contrast agents.
P F Renshaw1, C S Owen, A E Evans
1Department of Biochemistry, School of Medicine, University of Pennsylvania, Philadelphia 19104.
Magnetic Resonance Imaging
|January 1, 1986
Summary
Superparamagnetic particles offer highly effective NMR contrast at subnanomolar concentrations, outperforming traditional paramagnetic agents. These novel agents show specific binding for targeted cancer cell imaging.
Area of Science:
- Biomedical Imaging
- Nanotechnology
- Nuclear Magnetic Resonance (NMR)
Background:
- Traditional paramagnetic NMR contrast agents require high concentrations (around 1 mM) for effective use.
- Existing contrast agents have limitations in sensitivity and specificity for certain applications.
Purpose of the Study:
- To develop and evaluate novel NMR contrast agents effective at subnanomolar concentrations.
- To investigate the utility of superparamagnetic particles coupled to antibodies for targeted imaging.
Main Methods:
- Coupling of two different sized superparamagnetic particles to monoclonal antibodies.
- Testing the specific binding of these antibody-conjugated particles in vitro and in vivo.
- Assessing the NMR contrast enhancement capabilities of the novel agents.
Main Results:
- Superparamagnetic particles demonstrated effective NMR relaxation at subnanomolar concentrations.
- Specific binding of the antibody-conjugated particles to neuroblastoma cells was confirmed both in vitro and in vivo.
- Significant immunospecific NMR contrast was achieved.
Conclusions:
- Macromolecular superparamagnetic particles represent a breakthrough in NMR contrast agent sensitivity.
- Targeted delivery using antibody conjugation enables highly specific and sensitive NMR imaging.
- These findings open new avenues for sensitive cancer diagnostics and imaging.